Schedule 13D ownership disclosure
SINGULAR GENOMICS SYSTEMS IN
Common Stock, par value $0.0001 per share · CUSIP: 82933R308
Event date: 2024-12-22
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Deerfield Mgmt IV, L.P.Reported CIK 0001713467
Shares: 249,495.00 · Class: 6.62%
- Deerfield Private Design Fund IV, L.P.Reported CIK 0001680307
Shares: 249,495.00 · Class: 6.62%
- Deerfield Management Company, L.P.Reported CIK 0001009258
Shares: 249,495.00 · Class: 6.62%
- James E. FlynnReported CIK 0001352546
Shares: 249,495.00 · Class: 6.62%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001193805-24-001536
- Form type
- SCHEDULE 13D/A
- Filer
- Flynn James E
- CIK
- CIK 1352546
- Filed
- Dec 26, 2024
- Reporting period
- Dec 22, 2024
- Description
- Schedule 13D beneficial ownership